Advertisement
Advertisement

EYPT

EYPT logo

EyePoint, Inc. Common Stock

13.52
USD
Sponsored
-1.23
-8.33%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

13.59

+0.07
+0.50%

EYPT Earnings Reports

Positive Surprise Ratio

EYPT beat 14 of 28 last estimates.

50%

Next Report

Date of Next Report
Mar 03, 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.03M
/
-$0.76
Implied change from Q3 25 (Revenue/ EPS)
+6.65%
/
-10.59%
Implied change from Q4 24 (Revenue/ EPS)
-91.11%
/
+18.75%

EyePoint, Inc. Common Stock earnings per share and revenue

On Nov 05, 2025, EYPT reported earnings of -0.85 USD per share (EPS) for Q3 25, missing the estimate of -0.80 USD, resulting in a -6.18% surprise. Revenue reached 966.00 thousand, compared to an expected 3.40 million, with a -71.55% difference. The market reacted with a -11.10% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analysts forecast an EPS of -0.76 USD, with revenue projected to reach 1.03 million USD, implying an decrease of -10.59% EPS, and increase of 6.65% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, EyePoint, Inc. Common Stock reported EPS of -$0.85, missing estimates by -6.18%, and revenue of $966.00K, -71.55% below expectations.
The stock price moved down -11.1%, changed from $12.39 before the earnings release to $11.02 the day after.
The next earning report is scheduled for Mar 03, 2026.
Based on 14 analysts, EyePoint, Inc. Common Stock is expected to report EPS of -$0.76 and revenue of $1.03M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement